Related Experiment Video
Updated: Jul 7, 2026
09:32
A Next-generation Tissue Microarray (ngTMA) Protocol for Biomarker Studies
Published on: September 23, 2014
Tissue microarrays in clinical oncology.
David Voduc1, Challayne Kenney, Torsten O Nielsen
1Department of Radiation Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. dvoduc@bccancer.bc.ca
Seminars in Radiation Oncology
|March 4, 2008
Summary
Tissue microarray (TMA) technology enables rapid analysis of molecular markers in thousands of tumor samples. This high-throughput tool is invaluable for studying tumor biology and developing diagnostic tests in oncology.
Area of Science:
- Oncology
- Molecular Biology
- Biotechnology
Background:
- Tissue microarray (TMA) is a high-throughput technology for analyzing molecular markers in oncology.
- It allows rapid assessment of biomarkers in thousands of tumor samples using standard assays like immunohistochemistry and in situ hybridization.
Purpose of the Study:
- To review the impact of TMA-based research in clinical oncology.
- To discuss the potential future applications of TMA technology.
- To describe technical aspects, advantages, and disadvantages of TMA construction.
Main Methods:
- Review of existing literature on TMA applications in oncology.
- Discussion of technical considerations for TMA construction.
- Analysis of TMA's role in biomarker research and diagnostic development.
Main Results:
- TMA has become an invaluable tool in tumor biology studies, diagnostic test development, and biomarker investigation.
- The technology facilitates high-throughput analysis, accelerating research in clinical oncology.
Conclusions:
- Tissue microarray technology significantly impacts oncology research by enabling efficient biomarker analysis.
- TMA is crucial for advancing tumor biology understanding, diagnostic development, and future oncologic research.
